Genoox is a global company founded by an experienced team of geneticists, bioinformaticians, engineers and technology experts with a passion for life science, big data, high-performance computing, and a clear vision to revolutionize the way genomic data is shared, stored and analyzed.
We’ve translated our experience and core capabilities, creating the gold standard for clinical genomic analysis, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients.
Genoox removes the final barrier to the widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Our platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning. Genoox has an international footprint, with U.S. offices in Palo Alto, CA. The company was founded in 2014.
Genoox specializes in translating complex genetic data into clear, timely, and actionable clinical answers and offers a cloud-based software platform that manages the entire genetic sequencing process in an “end to end” fashion, from raw data collection to delivering clinical insights.